GlassScriptPhysician profile
Benjamin Burke Clippinger
NPI 1619380276
$4,468.52
in general payments reported to CMS, 2019-2025
14 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $185 · 2021: $1,926 · 2022: $1,750 · 2023: $295 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368 · Consulting Fee: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.75 |
| Consulting Fee | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,693.22 | 2021-2023 | |
| Arthrex, INC. | $1,364.37 | 2019-2022 | |
| Checkpoint Surgical, INC | $345.76 | 2022 | |
| Boston Scientific Corporation | $275.85 | 2020-2021 | |
| Stryker Corporation | $237.86 | 2020-2025 | Mako |
| Gotham Surgical Solutions & Devices, INC. | $191.84 | 2020-2022 | |
| Nevro Corp. | $110.00 | 2023 | Senza |
| Fx Shoulder Solutions, INC | $70.29 | 2021 | |
| Zimmer Biomet Holdings, INC. | $52.34 | 2023 | Tapestry, Comprehensive Shoulder System |
| Bioventus LLC | $49.26 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Arbor Pharmaceuticals, INC. | $27.94 | 2021 | |
| Pacira Therapeutics, INC. | $18.56 | 2021 | |
| Endo Pharmaceuticals INC. | $17.49 | 2020 | |
| Medartis INC. | $13.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Clippinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.